| __timestamp | AstraZeneca PLC | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5842000000 | 570979 |
| Thursday, January 1, 2015 | 4646000000 | 2185000 |
| Friday, January 1, 2016 | 4126000000 | 4554000 |
| Sunday, January 1, 2017 | 4318000000 | 3605000 |
| Monday, January 1, 2018 | 4936000000 | 5527000 |
| Tuesday, January 1, 2019 | 4921000000 | 5234000 |
| Wednesday, January 1, 2020 | 5299000000 | 6126000 |
| Friday, January 1, 2021 | 12437000000 | 6784000 |
| Saturday, January 1, 2022 | 12391000000 | 7592000 |
| Sunday, January 1, 2023 | 8040000000 | 11450000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. AstraZeneca PLC, a global leader, has seen its cost of revenue fluctuate significantly over the past decade. From 2014 to 2023, AstraZeneca's cost of revenue increased by approximately 38%, peaking in 2021 and 2022. This reflects strategic investments in research and development, crucial for maintaining its competitive edge.
Conversely, Travere Therapeutics, Inc., a smaller player, has experienced a more modest growth in cost of revenue, rising nearly 20 times from 2014 to 2023. This surge underscores Travere's expansion efforts and its commitment to innovation in rare disease treatments.
These trends highlight the contrasting scales and strategies of these companies, offering valuable insights into their operational dynamics and market positioning.
Cost of Revenue: Key Insights for AbbVie Inc. and Travere Therapeutics, Inc.
AstraZeneca PLC vs Vertex Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: AstraZeneca PLC vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down AstraZeneca PLC and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: AstraZeneca PLC vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: GSK plc vs Travere Therapeutics, Inc.
United Therapeutics Corporation vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Incyte Corporation vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs Travere Therapeutics, Inc.
Cost of Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs Travere Therapeutics, Inc.
Cost Insights: Breaking Down Travere Therapeutics, Inc. and MiMedx Group, Inc.'s Expenses